1887

Journal of General Virology header logo

Volume 80, Issue 6

Serum and intestinal isotype antibody responses to Wa human rotavirus in gnotobiotic pigs are modulated by maternal antibodies Free

Abstract

The effects of passive antibodies on protection and active immune responses to human rotavirus were studied in gnotobiotic pigs. Pigs were injected at birth with saline or sow serum of high (immunized) or low (control) antibody titre and subsets of pigs were fed colostrum and milk from immunized or control sows. Pigs were inoculated at 3-5 days of age and challenged at 21 days post-inoculation (p.i.) with virulent Wa human rotavirus. Pigs receiving immune serum with or without immune colostrum/milk were partially protected against diarrhoea and virus shedding after inoculation, but had significantly lower IgA antibody titres in serum and small intestinal contents at 21 days p.i. and lower protection rates after challenge compared with pigs given control or no maternal antibodies. IgG antibody titres were consistently higher in small than in large intestinal contents. Pigs given control serum with control colostrum/milk had lower rates of virus shedding after inoculation than those given control serum alone. In summary, high titres of circulating maternal antibodies with or without local (milk) antibodies provided passive protection after inoculation but suppressed active mucosal antibody responses. These findings may have implications for the use of live, oral rotavirus vaccines in breast-fed infants.

  • Received:
  • Accepted:
  • Published Online:
© Journal of General Virology 1999
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-80-6-1417
1999-06-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/80/6/0801417a.html?itemId=/content/journal/jgv/10.1099/0022-1317-80-6-1417&mimeType=html&fmt=ahah

References

  1. Banks K. L., McGuire T. C. 1989; Neonatal immunology. In Veterinary Clinical Immunology pp 193–204 Edited by Halliwell R. E. W., Gorman N. T. Philadelphia: W. B. Saunders;
     [Google Scholar]
  2. Barnes G. L., Uren E., Stevens K. B., Bishop R. F. 1998; Etiology of acute gastroenteritis in hospitalized children in Melbourne, Australia, from April 1980 to March 1993. Journal of Clinical Microbiology 36:133–138
     [Google Scholar]
  3. Bern C., Glass R. I. 1994; Impact of diarrheal diseases worldwide. In Viral Infection of the Gastrointestinal Tract 2nd edn, pp 1–26 Edited by Kapikian A. New York: Marcel Dekker;
     [Google Scholar]
  4. Bernstein D. I., Glass R. I., Rodgers G., Davidson B. L., Sack D. A. 1995; Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US Rotavirus Vaccine Efficacy Group. Journal of the American Medical Association 273:1191–1196
     [Google Scholar]
  5. Besser T. E., McGuire T. C., Gay C. C., Pritchett L. C. 1988a; Transfer of functional immunoglobulin G (IgG) antibody into the gastrointestinal tract accounts for IgG clearance in calves. Journal of Virology 62:2234–2237
     [Google Scholar]
  6. Besser T. E., Gay C. C., McGuire T. C., Evermann J. F. 1988b; Passive immunity to bovine rotavirus infection associated with transfer of serum antibody into the intestinal lumen. Journal of Virology 62:2238–2242
     [Google Scholar]
  7. Bishop R. F., Barnes G. L., Cipriani E., Lund J. S. 1983; Clinical immunity after neonatal rotavirus infection. A prospective longitudinal study in young children. New England Journal of Medicine 309:72–76
     [Google Scholar]
  8. Bishop R. F., Bugg H. C., Masendycz P. J., Lund J. S., Gorrell R. J., Barnes G. L. 1996; Serum, fecal, and breast milk rotavirus antibodies as indices of infection in mother–infant pairs. Journal of Infectious Diseases 174: (Suppl. 1) S22–S29
     [Google Scholar]
  9. Bohl E. H., Saif L. J., Theil K. W., Agnes A. G., Cross R. F. 1982; Porcine pararotavirus: detection, differentiation from rotavirus, and pathogenesis in gnotobiotic pigs. Journal of Clinical Microbiology 15:312–319
     [Google Scholar]
  10. Clemens J., Rao M., Ahmed F., Ward R., Huda S., Chakraborty J., Yunus M., Khan M. R., Ali M., Kay B., van Loon F., Sack D. 1993; Breast-feeding and the risk of life-threatening rotavirus diarrhea: prevention or postponement?. Pediatrics 92:680–685
     [Google Scholar]
  11. Coulson B. S., Grimwood K., Masendycz P. J., Lund J. S., Mermel-stein N., Bishop R. F., Barnes G. L. 1990; Comparison of rotavirus immunoglobulin A coproconversion with other indices of rotavirus infection in a longitudinal study in childhood. Journal of Clinical Microbiology 28:1367–1374
     [Google Scholar]
  12. Coulson B. S., Grimwood K., Hudson I. L., Barnes G. L., Bishop R. F. 1992; Role of coproantibody in clinical protection of children during reinfection with rotavirus. Journal of Clinical Microbiology 30:1678–1684
     [Google Scholar]
  13. Fernandez F. M., Conner M. E., Hodgins D. C., Parwani A. V., Nielsen P. R., Crawford S. E., Estes M. K., Saif L. J. 1998; Passive immunity to bovine rotavirus in newborn calves fed colostrum supplements from cows immunized with recombinant SA11 rotavirus core-like particle (CLP) or virus-like particle (VLP) vaccines. Vaccine 16:507–516
     [Google Scholar]
  14. Flores J., White L., Blanco M., Perez-Schael I. 1994; Serological response to rotavirus infection in newborn infants. Journal of Medical Virology 42:97–102
     [Google Scholar]
  15. Friedman M. G., Segal B., Zedaka R., Sarov B., Margalith M., Bishop R., Dagan R. 1993; Serum and salivary responses to oral tetravalent reassortant rotavirus vaccine in newborns. Clinical and Experimental Immunology 92:194–199
     [Google Scholar]
  16. Glass R. I., Ing D. J., Stoll B. J., Ing R. T. 1991; Immune response to rotavirus vaccines among breast-fed and non-breast fed children. In Immunology of Milk and the Neonate pp 249–254 Edited by Mestecky J., Blair C., Ogra P. L. New York: Plenum Press;
     [Google Scholar]
  17. Glass R. I., Kilgore P. E., Holman R. C., Jin S., Smith J. C., Woods P. A., Clarke M. J., Ho M. S., Gentsch J. R. 1996; The epidemiology of rotavirus diarrhea in the United States: surveillance and estimates of disease burden. Journal of Infectious Diseases 174: (Suppl. 1) S5–S11
     [Google Scholar]
  18. Hodgins D. C., Kang S. Y., deArriba L., Parreño V., Ward L. A., Yuan L., Tô T., Saif L. J. 1999; Effects of maternal antibodies on protection and development of antibody responses to human rotavirus in gnotobiotic pigs. Journal of Virology 73:186–197
     [Google Scholar]
  19. Joensuu J., Koskenniemi E., Pang X. L., Vesikari T. 1997; Randomised placebocontrolled trial of rhesus–human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis. Lancet 350:1205–1209
     [Google Scholar]
  20. Johansen K., Svensson L. 1997; Neutralization of rotavirus and recognition of immunologically important epitopes on VP4 and VP7 by human IgA. Archives of Virology 142:1491–1498
     [Google Scholar]
  21. Kapikian A. Z., Hoshino Y., Chanock R. M., Perez-Schael I. 1996; Efficacy of a quadrivalent rhesus rotavirus–based human rotavirus vaccine aimed at preventing severe rotavirus diarrhea in infants and young children. Journal of Infectious Diseases 174: (Suppl. 1) S65–S72
     [Google Scholar]
  22. Lanata C. F., Midthun K., Black R. E., Butron B., Huapaya A., Penny M. E., Ventura G., Gil A., Jett-Goheen M., Davidson B. L. 1996; Safety, immunogenicity, and protective efficacy of one and three doses of the tetravalent rhesus rotavirus vaccine in infants in Lima, Peru. Journal of Infectious Diseases 174:268–275
     [Google Scholar]
  23. Linhares A. C., Gabbay Y. B., Mascarenhas J. D. P., de Freitas R. B., Oliveira C. S., Bellesi N., Monteiro T. A. F., Lins-Lainson Z., Ramos F. L. P., Valente S. A. 1996; Immunogenicity, safety and efficacy of tetravalent rhesus-human, reassortant rotavirus vaccine in Belém, Brazil. Bulletin of the World Health Organization 74:491–500
     [Google Scholar]
  24. Marwick C. 1998; Rotavirus vaccine a boon to children. Journal of the American Medical Association 279:489–490
     [Google Scholar]
  25. Matson D. O., O’Ryan M. L., Herrera I., Pickering L. K., Estes M. K. 1993; Fecal antibody responses to symptomatic and asymptomatic rotavirus infections. Journal of Infectious Diseases 167:577–583
     [Google Scholar]
  26. Meyer R. C., Bohl E. H., Kohler E. M. 1964; Procurement and maintenance of germfree swine for microbiological investigation. Applied Microbiology 12:295–300
     [Google Scholar]
  27. Migasena S., Simasathien S., Samakoses R., Pitisuttitham P., Sangaroon P., van Steenis G., Beuvery E. C., Bugg H., Bishop R., Davidson B. L., Vesikari T. 1995; Simultaneous administration of oral rhesus–human reassortant tetravalent (RRV-TV) rotavirus vaccine and oral poliovirus vaccine (OPV) in Thai infants. Vaccine 13:168–174
     [Google Scholar]
  28. Parashar U. D., Holman R. C., Clarke M. J., Bresee J. S., Glass R. I. 1998; Hospitalizations associated with rotavirus diarrhea in the United States, 1993 through 1995: surveillance based on the new ICD-9-CM rotavirus-specific diagnostic code. Journal of Infectious Diseases 177:13–17
     [Google Scholar]
  29. Paul P. S., Mengeling W. L., Malstrom C. E., van Deusen R. A. 1989; Production and characterization of monoclonal antibodies to porcine immunoglobulin gamma, alpha, and light chains. American Journal of Veterinary Research 50:471–479
     [Google Scholar]
  30. Perez-Schael I., Guntinas M. J., Perez M., Pagone V., Rojas A. M., Gonzalez R., Cunto W., Hoshino Y., Kapikian A. Z. 1997; Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela. New England Journal of Medicine 337:1181–1187
     [Google Scholar]
  31. Periwal S. B., Speaker T. J., Cebra J. J. 1997; Orally administered microencapsulated reovirus can bypass suckled, neutralizing maternal antibody that inhibits active immunization of neonates. Journal of Virology 71:2844–2850
     [Google Scholar]
  32. Pichichero M.E. 1990; Effect of breast–feeding on oral rhesus rotavirus vaccine seroconversion: a metaanalysis. Journal of Infectious Diseases 162:753–755
     [Google Scholar]
  33. Quan C. P., Ruffet E., Arihiro K., Pires R., Bouvet J. P. 1996; High affinity serum-derivedFab fragments as another source ofantibodies in the gut lumen of both neonates and adults. Scandinavian Journal of Immunology 44:108–114
     [Google Scholar]
  34. Rennels M. B. 1996; Influence of breast–feeding and oral poliovirus vaccine on the immunogenicity and efficacy of rotavirus vaccines. Journal of Infectious Diseases 174: (Suppl. 1) S107–S111
     [Google Scholar]
  35. Rennels M. B., Glass R. I., Dennehy P. H., Bernstein D. I., Pichichero M. E., Zito E. T., Mack M. E., Davidson B. L., Kapikian A. Z. 1996; Safety and efficacy of high-dose rhesus–human reassortant rotavirus vaccines – report of the National Multicenter Trial. United States Rotavirus Vaccine Efficacy Group. Pediatrics 97:7–13
     [Google Scholar]
  36. Rimer H. C., Wasserman S. S., Flores J., Pichichero M. E., Losonsky G. A. 1992; Rotavirus-specific breast milk antibody in two populations and possible correlates of interference with rhesus rotavirus vaccine seroconversion. Journal of Infectious Diseases 165:826–830
     [Google Scholar]
  37. Ryan M. J., Ramsay M., Brown D., Gay N. J., Farrington C. P., Wall P. G. 1996; Hospital admissions attributable to rotavirus infection in England and Wales. Journal of Infectious Diseases 174: (Suppl. 1) S12–S18
     [Google Scholar]
  38. Saif L. J., Redman D. R., Smith K. L., Theil K. W. 1983; Passive immunity to bovine rotavirus in newborn calves fed colostrum supplements from immunized or nonimmunized cows. Infection and Immunity 41:1118–1131
     [Google Scholar]
  39. Schaller J. P., Saif L. J., Cordle C. T., Candler E. Jr, Winship T. R., Smith K. L. 1992; Prevention of human rotavirus-induced diarrhea in gnotobiotic piglets using bovine antibody. Journal of Infectious Diseases 165:623–630
     [Google Scholar]
  40. Tô T. L., Ward L. A., Yuan L., Saif L. J. 1998; Serum and intestinal isotype antibody responses and correlates of protective immunity to human rotavirus in a gnotobiotic pig model of disease. Journal of General Virology 79:2661–2672
     [Google Scholar]
  41. Turner R. B., Kelsey D. K. 1993; Passive immunization for prevention of rotavirus illness in healthy infants. Pediatric Infectious Disease Journal 12:718–722
     [Google Scholar]
  42. Van Binnendijk R. S., Poelen M. C., van Amerongen G., de Vries P., Osterhaus A. D. 1997; Protective immunity in macaques vaccinated with live attenuated, recombinant, and subunit measles vaccines in the presence of passively acquired antibodies. Journal of Infectious Diseases 175:524–532
     [Google Scholar]
  43. Velazquez F. R., Matson D. O., Calva J. J., Guerrero L., Morrow A. L., Carter-Campbell S., Glass R. I., Estes M. K., Pickering L. K., Ruiz-Palacios G. M. 1996; Rotavirus infection in infants as protection against subsequent infections. New England Journal of Medicine 335:1022–1028
     [Google Scholar]
  44. Vesikari T. 1997; Rotavirus vaccines against diarrhoeal disease. Lancet 350:1538–1541
     [Google Scholar]
  45. Vial P. A., Kotloff K. L., Losonsky G. A. 1988; Molecular epidemiology of rotavirus infection in a room for convalescing newborns. Journal of Infectious Diseases 157:668–673
     [Google Scholar]
  46. Ward R.L., Bernstein D.I. 1994; Protection against rotavirus disease after natural rotavirus infection. US Rotavirus Vaccine Efficacy Group. Journal of Infectious Diseases 169:900–904
     [Google Scholar]
  47. Ward L. A., Rich E. D., Besser T. E. 1996a; Role of maternally derived circulating antibodies in protection of neonatal swine against porcine group A rotavirus. Journal of Infectious Diseases 174:276–282
     [Google Scholar]
  48. Ward L. A., Rosen B. I., Yuan L., Saif L. J. 1996b; Pathogenesis of an attenuated and a virulent strain of group A human rotavirus in neonatal gnotobiotic pigs. Journal of General Virology 77:1431–1441
     [Google Scholar]
  49. Ward R. L., Knowlton D. R., Zito E. T., Davidson B. L., Rappaport R., Mack M. E. 1997; Serolog ic correlates of immunity in a tetravalent reassortant rotavirus vaccine trial. US Rotavirus Vaccine Efficacy Group. Journal of Infectious Diseases 176:570–577
     [Google Scholar]
  50. Wyatt R. G., James W. D., Bohl E. H., Theil K. W., Saif L. J., Kalica A. R., Greenberg H. B., Kapikian A. Z., Chanock R. M. 1980; Human rotavirus type 2: cultivation in vitro. Science 207:189–191
     [Google Scholar]
  51. Yuan L., Ward L.A., Rosen B.I., To T.L., Saif L.J. 1996; Systemic and intestinal antibody-secreting cell responses and correlates of protective immunity to human rotavirus in a gnotobiotic pig model of disease. Journal of Virology 70:3075–3083
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-80-6-1417
Loading
Serum and intestinal isotype antibody responses to Wa human rotavirus in gnotobiotic pigs are modulated by maternal antibodies
J. Gen. Virol. 80, 1417 (1999); https://doi.org/10.1099/0022-1317-80-6-1417
/content/journal/jgv/10.1099/0022-1317-80-6-1417
/content/journal/jgv/10.1099/0022-1317-80-6-1417
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error